Advanced search
Publication Cover
Current Medical Research and Opinion Volume 34, 2018 - Issue 6: Diabetes
Submit an article Journal homepage
3,044
Views
16
CrossRef citations to date
0
Altmetric
Diabetes

Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period

Yutaka SeinoKansai Electric Power Hospital, Osaka, Japan; ;Kansai Electric Power Medical Research Institute, Kobe, Japan;
,
Takashi SasakiInstitute of Clinical Medicine and Research, The Jikei University School of Medicine, Chiba, Japan;
,
Atsushi FukatsuYachiyo Hospital, Aichi, Japan;
,
Hisae ImazekiTaisho Pharmaceutical Co. Ltd., Tokyo, JapanCorrespondence[email protected]
,
Hidekazu OchiaiTaisho Pharmaceutical Co. Ltd., Tokyo, Japan
&
Soichi SakaiTaisho Pharmaceutical Co. Ltd., Tokyo, Japan
Pages 981-994 | Received 24 Nov 2017, Accepted 13 Feb 2018, Published online: 20 Mar 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.